Stockscreener 앱 받기
3.05
1.93%
-0.06
시간 외 거래:
3.02
-0.03
-0.98%
전일 마감가:
$3.11
열려 있는:
$3.12
하루 거래량:
24,732
Relative Volume:
0.06
시가총액:
$9.28M
수익:
-
순이익/손실:
$2.81M
주가수익비율:
-0.2125
EPS:
-14.3497
순현금흐름:
$7.14M
1주 성능:
-3.17%
1개월 성능:
-0.65%
6개월 성능:
-20.37%
1년 성능:
-34.83%
1일 변동 폭
$3.04
$3.13
1주일 범위
$2.96
$3.29
52주 변동 폭
$2.51
$4.80
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
명칭
Kiora Pharmaceuticals Inc
전화
781-788-8869
주소
332 ENCINITAS BOULEVARD, ENCINITAS
KPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
3.05 | 9.22M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc 주식(KPRX)의 최신 뉴스
What analysts say about Kiora Pharmaceuticals Inc. stockExceptional risk-adjusted gains - Autocar Professional
Kiora Pharmaceuticals Secures US Patent for KIO-104 - Ophthalmology Times
What drives Kiora Pharmaceuticals Inc. stock priceConsistent high-performance stocks - Autocar Professional
Kiora Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional
KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus
Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals receives patent for ocular disease treatment By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com Australia
Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan
Is Kiora Pharmaceuticals Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com
Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN
Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com
How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
What makes Kiora Pharmaceuticals Inc. stock price move sharplyPredictable Return Stock Picks - Newser
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World
Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times
kiora pharmaceuticals reports results of annual shareholder meeting By Investing.com - Investing.com South Africa
kiora pharmaceuticals reports results of annual shareholder meeting - Investing.com
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors - TipRanks
Oil Prices Climb While US Equity Futures Stutter - Finimize
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard SurgeMore Stocks Inside! - openPR.com
Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside! - FinancialContent
Markets | American Financial Group, Inc. - FinancialContent
Kiora Pharmaceuticals inks potential $110 million deal with Senju By Investing.com - Investing.com South Africa
ReShape Lifesciences And Kiora Pharma Impress Investors, Dollar General Uplifts Outlook - Finimize
Sector Update: Health Care - marketscreener.com
Kiora Pharmaceuticals Stock Skyrockets Over 20% in Dynamic Trading Session - Daily Chhattisgarh News
Traws Pharma Inc. Stock Skyrockets Over 40%, Then Pares Gains in Volatile Trading - Daily Chhattisgarh News
Kiora Pharmaceuticals Inc (KPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.32%
1.57%
자본화:
|
볼륨(24시간):